BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31495828)

  • 1. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
    Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
    Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast density in NF1 women: a retrospective study.
    De Santis R; Cagnoli G; Rinaldi B; Consonni D; Conti B; Eoli M; Liguori A; Cosentino M; Carrafiello G; Garrone O; Giroda M; Cesaretti C; Sfondrini MS; Gambini D; Natacci F
    Fam Cancer; 2024 Mar; 23(1):35-40. PubMed ID: 38270845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.
    Sharif S; Moran A; Huson SM; Iddenden R; Shenton A; Howard E; Evans DG
    J Med Genet; 2007 Aug; 44(8):481-4. PubMed ID: 17369502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of breast cancer in women with NF1.
    Madanikia SA; Bergner A; Ye X; Blakeley JO
    Am J Med Genet A; 2012 Dec; 158A(12):3056-60. PubMed ID: 23165953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
    Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
    Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Detection of
    Bianchessi D; Ibba MC; Saletti V; Blasa S; Langella T; Paterra R; Cagnoli GA; Melloni G; Scuvera G; Natacci F; Cesaretti C; Finocchiaro G; Eoli M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32575496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
    Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
    Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
    Yap YS; Munusamy P; Lim C; Chan CHT; Prawira A; Loke SY; Lim SH; Ong KW; Yong WS; Ng SBH; Tan IBH; Callen DF; Lim JCT; Thike AA; Tan PH; Lee ASG
    Breast Cancer Res Treat; 2018 Oct; 171(3):719-735. PubMed ID: 29926297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.
    Wang X; Teer JK; Tousignant RN; Levin AM; Boulware D; Chitale DA; Shaw BM; Chen Z; Zhang Y; Blakeley JO; Acosta MT; Messiaen LM; Korf BR; Tainsky MA
    Genes Chromosomes Cancer; 2018 Jan; 57(1):19-27. PubMed ID: 28891274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline and Somatic
    Wang X; Kallionpää RA; Gonzales PR; Chitale DA; Tousignant RN; Crowley JP; Chen Z; Yoder SJ; Blakeley JO; Acosta MT; Korf BR; Messiaen LM; Tainsky MA
    Cancer Prev Res (Phila); 2018 Oct; 11(10):655-664. PubMed ID: 30104415
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary hypertension in patients with neurofibromatosis type I.
    Montani D; Coulet F; Girerd B; Eyries M; Bergot E; Mal H; Biondi G; Dromer C; Hugues T; Marquette C; O'Connell C; O'Callaghan DS; Savale L; Jaïs X; Dorfmüller P; Begueret H; Bertoletti L; Sitbon O; Bellanné-Chantelot C; Zalcman G; Simonneau G; Humbert M; Soubrier F
    Medicine (Baltimore); 2011 May; 90(3):201-211. PubMed ID: 21512413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
    Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
    Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
    Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
    J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis 1: closing the GAP between mice and men.
    Dasgupta B; Gutmann DH
    Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-aortic syndrome with renovascular hypertension and multisystem involvement in a girl with familiar neurofibromatosis von Recklinghausen type 1.
    Petrak B; Bendova S; Seeman T; Klein T; Lisy J; Zatrapa T; Marikova T
    Neuro Endocrinol Lett; 2007 Dec; 28(6):734-8. PubMed ID: 18063929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1.
    Cimino PJ; Gutmann DH
    Handb Clin Neurol; 2018; 148():799-811. PubMed ID: 29478615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
    Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific risk of breast cancer in women with neurofibromatosis type 1.
    Seminog OO; Goldacre MJ
    Br J Cancer; 2015 Apr; 112(9):1546-8. PubMed ID: 25742481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor.
    Park GH; Lee SJ; Lee CG; Kim J; Park E; Jeong SY
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.